Related Experiment Video
Updated: Aug 29, 2026

Combination of Microstereolithography and Electrospinning to Produce Membranes Equipped with Niches for Corneal Regeneration
Published on: September 12, 2014
[Suppression of corneal neovascularization by conditioned culture medium of human amniotic membrane]
Xiang Ma1, Haydee Bazan, Jun Li
1Department of Ophthalmology, First Affiliated Hospital of Dalian Medical University, Dalian 116011, China. xma9467@hotmail.com
Objective:
To investigate the effects of the conditioned culture medium (CCM) of human amniotic membrane (AM) on corneal neovascularization (CNV) induced by basic fibroblast growth factor (bFGF) in mice.
Methods:
AM (with epithelium side up) was cultured in EGM basic medium for 3 days, and the CCM was collected. The CCM consisted of three groups: control (EGM only), AM with epithelium (AM) and AM without epithelium (De-AM). Corneal neovascularization was induced in mice by using micropocket assay with Hydron polymer pellets containing 100 ng bFGF. Migration and proliferation of human umbilical cord vein endothelial cells (HUVEC) were measured in Boyden chambers and by CyQUANT fluorescence binding assay, respectively. The levels of tissue inhibitors of metalloproteinase 1 and 2 (TIMP-1, TIMP-2) in the CCM were determined by ELISA assay.
Results:
CNV induced by bFGF was significantly suppressed by the CCM of amniotic membrane. When CCM was applied as an eyedrop 4 times a day for 7 days, the area of CNV was (2.48 +/- 0.76) mm(2), (0.64 +/- 0.52) mm(2) and (1.96 +/- 0.65) mm(2) in control, AM and De-AM groups, respectively. The migration and proliferation of HUVEC were strongly inhibited by the CCM of AM with epithelium, while the De-AM had no effect on the migration of HUVEC cells. A high level of TIMP-2 was found in AM group, but not in De-AM group. There were no differences in the amount of TIMP-1 in medium among these three groups.
Conclusions:
CCM of amniotic membrane significantly suppresses the CNV induced by bFGF. One of the mechanisms of CCM-mediated suppression is that a high level of TIMP-2 protein is secreted or released into the CCM by AM, which can inhibit the migration and growth of vascular endothelial cells.
Insights
Human amniotic membrane conditioned medium (CCM) effectively suppresses corneal neovascularization (CNV) in mice. This effect is mediated by tissue inhibitor of metalloproteinase-2 (TIMP-2) in the CCM, inhibiting vascular endothelial cell growth.
Area of Science:
- Ophthalmology
- Regenerative Medicine
- Cell Biology
Context:
- Corneal neovascularization (CNV) is a pathological process involving the growth of new blood vessels into the cornea.
- Basic fibroblast growth factor (bFGF) is a potent inducer of CNV.
- Human amniotic membrane (AM) is known for its therapeutic properties in ocular surface diseases.
Purpose:
- To evaluate the efficacy of conditioned culture medium (CCM) derived from human AM in inhibiting bFGF-induced CNV in a mouse model.
- To investigate the underlying mechanisms, including the role of specific proteins, in AM-CCM's anti-angiogenic effects.
Summary:
- AM was cultured, and its CCM was collected. CNV was induced in mice using bFGF. The effects of CCM from AM with (AM) and without epithelium (De-AM) were assessed.
- AM-CCM significantly suppressed bFGF-induced CNV. AM-CCM, but not De-AM-CCM, inhibited human umbilical cord vein endothelial cell (HUVEC) migration and proliferation.
- Elevated levels of tissue inhibitor of metalloproteinase-2 (TIMP-2) were detected in AM-CCM, correlating with its anti-angiogenic activity.
Impact:
- This study demonstrates the potent anti-angiogenic potential of human AM-derived CCM for treating corneal neovascularization.
- The findings highlight TIMP-2 as a key mediator of AM-CCM's therapeutic effects, suggesting its potential as a therapeutic target.
- AM-CCM represents a promising cell-free therapeutic strategy for managing corneal neovascularization and related vascular eye diseases.
More Related Videos
11:13Adenoviral Gene Therapy for Diabetic Keratopathy: Effects on Wound Healing and Stem Cell Marker Expression in Human Organ-cultured Corneas and Limbal Epithelial Cells
Published on: April 7, 2016
12:36A Human Corneal Organ Culture Model of Descemet's Stripping Only with Accelerated Healing Stimulated by Engineered Fibroblast Growth Factor 1
Published on: July 22, 2022